Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

NIH New Initiative on Alzheimers:

"Since 1998 there have been more than 100 attempts to develop a treatment for Alzheimer’s and all have failed. More than 5 million Americans have Alzheimer’s disease, the most common form of dementia, a patient population that is expected to triple by 2050, according to the Alzheimer’s Association. As many as a half-million people in the U.S. may die from the disease each year, making it the country’s No. 3 killer, researchers reported last month in the journal Neurology."

"NIH also is teaming with pharmaceutical companies to study new approaches to treat Alzheimer’s, diabetes, lupus and arthritis. Collins said he worked with the companies’ research and development units for three years to make the “unprecedented” partnership happen. The research will be made public for any scientist to use"

...So, ask yourself, what does Alzheimers, diabetes, lupus and arthritis have in common? Answer: Chromic inflammation!

Article at:
http://www.bloomberg.com/news/2014-04-11/alzheimer-s-therapy-may-come-from-new-look-at-old-drugs.html